Press Releases

All Releases
AngioDynamics Reports 2015 Second Quarter Financial Results
Jan 08, 2015
Second Quarter Fiscal 2015 Net Sales increased 4% to $92.1 million ; 5% sales growth excluding supply agreement GAAP EPS of $0.04 ; Non-GAAP adjusted net income of $0.17 per share, a 21% YOY increase EBITDA of $11.9 million ; Adjusted EBITDA of $15.9 million , a 18% YOY increase Company raises
AngioDynamics to Present at 33rd Annual J.P. Morgan Healthcare Conference
Jan 06, 2015
ALBANY, N.Y. , Jan. 6, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer, is
AngioDynamics to Report Fiscal 2015 Second Quarter Financial Results
Dec 17, 2014
ALBANY, N.Y. , Dec. 17, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2015 second
AngioDynamics Awarded HealthTrust PICC Contract
Dec 09, 2014
ALBANY, N.Y. , Dec. 9, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it signed an agreement with HealthTrust covering PICC
AngioDynamics to Present at 26th Annual Piper Jaffray Healthcare Conference
Nov 25, 2014
ALBANY, N.Y. , Nov. 25, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer,
AngioDynamics to Present at Upcoming Investor Conferences
Nov 11, 2014
ALBANY, N.Y. , Nov. 11, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today the company will present at the following investor conferences
NanoKnife System Receives OPS Procedure Classification Codes in Germany
Oct 28, 2014
ALBANY, N.Y. , Oct. 28, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the Germany Ministry of Health has issued an OPS (a procedure
AngioDynamics to be Added to the S&P SmallCap 600 Index
Oct 13, 2014
ALBANY, N.Y. , Oct. 13, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today it will be added to the S&P SmallCap 600 Index and the GICS Life
AngioDynamics Reports 2015 First Quarter Financial Results
Oct 09, 2014
First Quarter of Fiscal 2015 Net sales increased 4% to $87.3 million ; Sales grew 5%, excluding supply agreement Q1 FY15 GAAP $0.02 ; Non-GAAP adjusted net income of $0.16 per share Q1 FY15 EBITDA of $10.8 million , Adjusted EBITDA of $15.3 million Company provides second quarter guidance and
AngioDynamics to Report Fiscal 2015 First Quarter Financial Results
Sep 25, 2014
ALBANY, N.Y. , Sept. 25, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2015 first
AngioDynamics Sponsors Second Annual St. Jude Gala
Aug 21, 2014

Event to Benefit St. Jude Children's Research Hospital
Honors WGNA; Features Performance by Big Sky Country

AngioDynamics to Present at Canaccord Genuity 34th Annual Growth Conference
Aug 07, 2014
ALBANY, N.Y. , Aug. 7, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today Joseph M. DeVivo , President and Chief Executive Officer, is
AngioDynamics Reports 2014 Fourth Quarter and Full Year Financial Results
Jul 23, 2014
Fourth Quarter of Fiscal 2014 Net sales increased 4% to $94.1 million ; Average Daily Sales grew 7%, excluding supply agreement Q4 FY14 GAAP loss of $0.03 per share; Non-GAAP adjusted net income, excluding amortization, of $0.18 per share Q4 FY14 Operating cash flow of $10.1 million Company
AngioDynamics Awarded Novation Innovative Technology Contract Covering BioFlo PICCs and BioFlo Ports
Jul 21, 2014
ALBANY, N.Y. , July 21, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today receipt of an Innovative Technology Contract for the Company's
AngioDynamics to Report Fiscal 2014 Fourth Quarter and Full Year Financial Results
Jul 08, 2014
ALBANY, N.Y. , July 8, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2014 fourth
AngioDynamics Announces FDA Clearance for Celerity Tip Location System
Jun 18, 2014
ALBANY, N.Y. , June 18, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration (FDA) has granted 510(k)
AngioDynamics Awarded Premier Inc.'s Supplier Horizon Award
Jun 11, 2014
ALBANY, N.Y. , June 11, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today it is a winner of Premier Inc.'s first Supplier Horizon Award ,
AngioDynamics to Present at Jefferies Global Healthcare Conference
May 28, 2014
ALBANY, N.Y. , May 28, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Mark Frost , Executive Vice President and Chief Financial
AngioDynamics to Present at Upcoming Investor Conferences
May 06, 2014
ALBANY, N.Y. , May 6, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today the company will present at the following investor conferences in
AngioDynamics Names Howard W. Donnelly Chairman of the Board of Directors
Apr 29, 2014
ALBANY, N.Y. , April 29, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced Howard W. Donnelly , 52, has been named Chairman of the Board
Displaying 81 - 100 of 615

Copyright Nasdaq. Minimum 15 minutes delayed.